• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Google Acquires Eye Tracking Startup Eyefluence for VR/AR Focus

by HITC Staff 10/25/2016 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

eyefluence

Google has acquired Eyefluence, an eye-interaction technology for AR, VR, and MR devices which transforms intent into action through the eyes. Financial terms of the acquisition were not disclosed. To date, the company has raised $21.6 million from Motorola Solutions Venture Capital, with participation from NHN Investment, Dolby Family Ventures, and Jazz Venture Partners. 

Traditional eye-tracking companies have tried to translate eye movement into a method for control using the same principles as the standard mouse, requiring users to wait and wink on objects to initiate action. This makes eye-tracking slow, unsatisfying, and straining – and it sacrifices concentration and vision for machine manipulation. Founded in 2013 by serial entrepreneur Jim Margraff, Eyefluence has developed the first user interface based on the eye-brain connection to enable vision-driven, intuitive eye-interaction. The Eyefluence iUi combines biology and technology and integrates into any AR, VR, or MR platform.

The acquisition validates Google’s interest into augmented reality and virtual reality apps. Google did not release any details on how it plans to integrate Eyefluence into its portfolio of products, services and features; however, Google could potentially use the intellectual property to further develop its smart contact lens for diabetes.

In 2015, the U.S. Patent & Trademark Office granted Google a patent for a “smart contact lens having an uneven embedded substrate and method of manufacture.” Many believe the smart contact lens patent could be used to monitor a wearer’s blood sugar levels. 

In blog post announcement Eyefluence stated:

“In early 2013, our journey began with a mission to transform intent into action through your eyes. We recognized an opportunity to create a more natural, intuitive way to interact with augmented and virtual reality displays. Over the last three and a half years we have built an incredible team, advanced our eye-interaction technology, and created strong partnerships that have lead to the development of a completely new language for eye-interaction”

“Today, we are excited to announce that the Eyefluence team is joining Google!  With our forces combined, we will continue to advance eye-interaction technology to expand human potential and empathy on an even larger scale.  We look forward to the life-changing innovations we’ll create together!”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Healthcare Mergers & Acquisitions

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

 Selecting the Right EMR: A Practical Guide to Streamlining Your Practice and Enhancing Patient Care

Selecting the Right EMR: A Practical Guide to Streamlining Your Practice and Enhancing Patient Care

Featured Interview

Virta Health CEO: GLP-1s Didn’t Kill Weight Watchers, Its Broken Model Did

Most-Read

Health IT Sector Navigates Policy Turbulence with Resilient M&A

Health IT’s New Chapter: IPOs Return, Resilient M&A, Valuations Rise in 1H 2025

PwC Report: US Medical Cost Trend to Remain Elevated at 8.5% in 2026

PwC Report: US Medical Cost Trend to Remain Elevated at 8.5% in 2026

Philips Launches ECG AI Marketplace, Partnering with Anumana to Enhance Cardiac Care with AI-Powered Diagnostics

Philips Launches ECG AI Marketplace, Partnering with Anumana to Enhance Cardiac Care with AI-Powered Diagnostics

WeightWatchers Emerges from Bankruptcy, Launches New Menopause Program

WeightWatchers Emerges from Bankruptcy, Launches New Menopause Program

CMS Finalizes New Interoperability and Prior Authorization Rule

CMS Proposes 2026 Physician Fee Schedule Rule: Boosting Primary Care, Cutting Waste, and Modernizing Payments

Beyond SaaS: How Agent as a Service is Transforming Healthcare Automation

Beyond SaaS: How Agent as a Service is Transforming Healthcare Automation

New Strategies Needed: No Surprises Act and the Challenges for Payors with Provider Data Inaccuracies

Samsung Acquires Xealth to Accelerate Connected Care Vision

Samsung Acquires Xealth to Accelerate Connected Care Vision

AI Dominates Digital Health Investment in First Half of 2025

Rock Health Report: AI Dominates Digital Health Investment in First Half of 2025

Moving Beyond EHRs: What Lies Ahead for Healthcare Digitization?

AI Agents vs. Chatbots: Understanding Agentic AI’s Role in Healthcare

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |